Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1430072

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1430072

Europe Hydrocephalus Market - Industry Trends and Forecast to 2033

PUBLISHED:
PAGES: 166 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

The Europe hydrocephalus market is expected to reach USD 577,379.08 thousand by 2031 from USD 368,048.70 thousand in 2023, growing with a CAGR of 6.0% in the forecast period of 2024 to 2031.

Market Segmentation

Europe Hydrocephalus Market, By Type (Congenital Hydrocephalus, Acquired Hydrocephalus, Normal-Pressure Hydrocephalus, and Ex-Vacuo Hydrocephalus), Diagnostic & Treatment (Diagnosis and Treatment), End Users (Hospitals, Clinics, Diagnostic Centers, and Academic Institutions and Research Organizations), Country (Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, Ireland, and Rest of Europe) - Industry Trends and Forecast to 2031.

Overview of Europe Hydrocephalus Market Dynamics

  • Driver
  • Increasing incidence of neurological conditions
  • Restraint
  • Poor reimbursement policies
  • Opportunity
  • Growing support by healthcare organizations and government bodies

Market Players

Some of the key market players operating in the Europe hydrocephalus market are:

  • Aesculap, Inc. - a B. Braun company
  • Integra LifeSciences
  • G.SURGIWEAR LTD
  • MOLLER Medical GmbH
  • Anuncia Inc.
  • CHRISTOPH MIETHKE GMBH & CO. KG
  • KARL STORZ SE & Co. KG
  • Proteses, inc.
  • Medtronic
  • natus
  • Desu Medical
  • Bicakcilar
  • Spiegelberg GmbH & Co.KG
  • Sophysa
  • KANEKA MEDIX CORP

TABLE OF CONTENTS

1 INTRODUCTION 31

  • 1.1 OBJECTIVES OF THE STUDY 31
  • 1.2 MARKET DEFINITION 31
  • 1.3 OVERVIEW OF EUROPE HYDROCEPHALUS MARKET 31
  • 1.4 LIMITATIONS 32
  • 1.5 MARKETS COVERED 32

2 MARKET SEGMENTATION 35

  • 2.1 MARKETS COVERED 35
  • 2.2 GEOGRAPHICAL SCOPE 36
  • 2.3 YEARS CONSIDERED FOR THE STUDY 37
  • 2.4 CURRENCY AND PRICING 37
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 38
  • 2.6 MULTIVARIATE MODELLING 41
  • 2.7 TYPE LIFELINE CURVE 41
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 42
  • 2.9 DBMR MARKET POSITION GRID 43
  • 2.10 VENDOR SHARE ANALYSIS 44
  • 2.11 SECONDARY SOURCES 45
  • 2.12 ASSUMPTIONS 45

3 EXECUTIVE SUMMARY 46

4 PREMIUM INSIGHTS 48

5 EUROPE HYDROCEPHALUS MARKET: REGULATIONS 49

  • 5.1 REGULATIONS IN U.S. 49
  • 5.2 REGULATIONS IN EUROPE 49
  • 5.3 REGULATIONS IN INDIA 49
  • 5.4 REGULATIONS IN JAPAN 50
  • 5.5 REGULATIONS IN BRAZIL 50

6 MARKET OVERVIEW 51

  • 6.1 DRIVERS 53
    • 6.1.1 INCREASING INCIDENCE OF NEUROLOGICAL CONDITIONS 53
    • 6.1.2 GROWING NUMBER OF NEW-BORNS AFFECTED BY HYDROCEPHALUS 53
    • 6.1.3 INCREASING ADAPTATION OF ADVANCED PROGRAMMABLE VALVES 54
    • 6.1.4 RISING AWARENESS ABOUT HYDROCEPHALUS 54

  • 6.2 RESTRAINTS 55
    • 6.2.1 POOR REIMBURSEMENT POLICIES 55
    • 6.2.2 DELETERIOUS COMPLICATIONS WITH HYDROCEPHALUS DEVICES 55
  • 6.3 OPPORTUNITIES 56
    • 6.3.1 GROWING SUPPORT BY HEALTHCARE ORGANIZATIONS AND GOVERNMENT BODIES 56
    • 6.3.2 GROWING HEALTHCARE EXPENDITURE 57
    • 6.3.3 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYERS 57
  • 6.4 CHALLENGES 58
    • 6.4.1 HIGH PRODUCT RECALL SCENARIO 58
    • 6.4.2 LACK OF ACCESSIBILITY OF HYDROCEPHALUS PRODUCTS 58

7 EUROPE HYDROCEPHALUS MARKET, BY TYPE 59

  • 7.1 OVERVIEW 60
  • 7.2 CONGENITAL HYDROCEPHALUS 63
  • 7.3 ACQUIRED HYDROCEPHALUS 63
  • 7.4 NORMAL-PRESSURE HYDROCEPHALUS 64
  • 7.5 EX-VACUO HYDROCEPHALUS 64

8 EUROPE HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT 65

  • 8.1 OVERVIEW 66
  • 8.2 DIAGNOSTICS 69
    • 8.2.1 MAGNETIC RESONANCE IMAGING (MRI) 69
    • 8.2.2 CT SCAN - HEAD 69
    • 8.2.3 HEAD ULTRASOUND 70
  • 8.3 TREATMENT 70
    • 8.3.1 SURGERY - SHUNT INSERTION, BY PRODUCT TYPE 71
      • 8.3.1.1 HYDROCEPHALUS VALVES 71
      • 8.3.1.2 HYDROCEPHALUS CATHETERS 71
        • 8.3.1.2.1 ADJUSTABLE PRESSURE VALVES 71
        • 8.3.1.2.2 FIX PRESSURE VALVES 72
    • 8.3.2 SURGERY - SHUNT INSERTION, BY AGE GROUP 72
      • 8.3.2.1 PEDIATRIC 72
      • 8.3.2.2 ADULT 72
    • 8.3.3 VENTRICULOSTOMY 72
    • 8.3.4 MEDICATION 72
    • 8.3.5 TREATMENT, BY AGE GROUP 73
    • 8.3.6 INFANTS 73
    • 8.3.7 CHILDREN 73
    • 8.3.8 ADULTS 73

9 EUROPE HYDROCEPHALUS MARKET, BY END USERS 74

  • 9.1 OVERVIEW 75
  • 9.2 HOSPITALS 78
  • 9.3 CLINICS 78
  • 9.4 DIAGNOSTIC CENTERS 79
  • 9.5 ACADEMIC INSTITUTIONS AND RESEARCH ORGANIZATIONS 79
    • 9.5.1 HOSPITALS 80
    • 9.5.2 AMBULATORY AND SURGICAL CENTERS 80
    • 9.5.3 HOSPITALS 80
    • 9.5.4 CLINICS 80
    • 9.5.5 DIAGNOSTIC CENTER 81
    • 9.5.6 SURGICAL CENTERS 81
    • 9.5.7 AMBULATORY SURGICAL CENTERS 81
    • 9.5.8 OTHERS 81

10 EUROPE HYDROCEPHALUS MARKET, BY REGION 82

  • 10.1 OVERVIEW 83
  • 10.2 EUROPE 85
    • 10.2.1 GERMANY 90
    • 10.2.2 FRANCE 94
    • 10.2.3 U.K. 98
    • 10.2.4 ITALY 102
    • 10.2.5 SPAIN 106
    • 10.2.6 RUSSIA 110
    • 10.2.7 TURKEY 114
    • 10.2.8 IRELAND 118
    • 10.2.9 BELGIUM 122
    • 10.2.10 NETHERLANDS 126
    • 10.2.11 SWITZERLAND 130
    • 10.2.12 REST OF EUROPE 134

11 EUROPE HYDROCEPHALUS MARKET, COMPANY LANDSCAPE 135

  • 11.1 COMPANY SHARE ANALYSIS: EUROPE 135

12 SWOT ANALYSIS 136

13 COMPANY PROFILE 137

  • 13.1 MEDTRONIC 137
    • 13.1.1 COMPANY SNAPSHOT 137
    • 13.1.2 REVENUE ANALYSIS 137
    • 13.1.3 COMPANY SHARE ANALYSIS 138
    • 13.1.4 PRODUCT PORTFOLIO 138
    • 13.1.5 RECENT DEVELOPMENTS 138
  • 13.2 AESCULAP, INC. - A B. BRAUN COMPANY 139
    • 13.2.1 COMPANY SNAPSHOT 139
    • 13.2.2 COMPANY SHARE ANALYSIS 139
    • 13.2.3 PRODUCT PORTFOLIO 140
    • 13.2.4 RECENT DEVELOPMENT 140
  • 13.3 INTEGRA LIFESCIENCES 141
    • 13.3.1 COMPANY SNAPSHOT 141
    • 13.3.2 REVENUE ANALYSIS 141
    • 13.3.3 COMPANY SHARE ANALYSIS 142
    • 13.3.4 PRODUCT PORTFOLIO 142
    • 13.3.5 RECENT DEVELOPMENT 143
  • 13.4 SPIEGELBERG GMBH & CO. KG 144
    • 13.4.1 COMPANY SNAPSHOT 144
    • 13.4.2 COMPANY SHARE ANALYSIS 144
    • 13.4.3 PRODUCT PORTFOLIO 145
    • 13.4.4 RECENT DEVELOPMENT 145
  • 13.5 BICAKCILAR 146
    • 13.5.1 COMPANY SNAPSHOT 146
    • 13.5.2 COMPANY SHARE ANALYSIS 146
    • 13.5.3 PRODUCT PORTFOLIO 147
    • 13.5.4 RECENT DEVELOPMENTS 147
  • 13.6 ANUNCIA INC 148
    • 13.6.1 COMPANY SNAPSHOT 148
    • 13.6.2 PRODUCT PORTFOLIO 148
    • 13.6.3 RECENT DEVELOPMENT 148
  • 13.7 CHRISTOPH MIETHKE GMBH & CO. KG 149
    • 13.7.1 COMPANY SNAPSHOT 149
    • 13.7.2 PRODUCT PORTFOLIO 149
    • 13.7.3 RECENT DEVELOPMENT 150

  • 13.8 DESU MEDICAL 151
    • 13.8.1 COMPANY SNAPSHOT 151
    • 13.8.2 PRODUCT PORTFOLIO 151
    • 13.8.3 RECENT DEVELOPMENT 151
  • 13.9 G.SURGIWEAR LTD 152
    • 13.9.1 COMPANY SNAPSHOT 152
    • 13.9.2 PRODUCT PORTFOLIO 152
    • 13.9.3 RECENT DEVELOPMENT 152
  • 13.10 HPBIO 153
    • 13.10.1 COMPANY SNAPSHOT 153
    • 13.10.2 PRODUCT PORTFOLIO 153
    • 13.10.3 RECENT DEVELOPMENT 153
  • 13.11 KANEKA MEDIX CORP 154
    • 13.11.1 COMPANY SNAPSHOT 154
    • 13.11.2 REVENUE ANALYSIS 154
    • 13.11.3 PRODUCT PORTFOLIO 156
    • 13.11.4 RECENT DEVELOPMENTS 156
  • 13.12 KARL STORZ SE & CO. KG 157
    • 13.12.1 COMPANY SNAPSHOT 157
    • 13.12.2 PRODUCT PORTFOLIO 157
    • 13.12.3 RECENT DEVELOPMENT 157
  • 13.13 MOLLER MEDICAL GMBH 158
    • 13.13.1 COMPANY SNAPSHOT 158
    • 13.13.2 PRODUCT PORTFOLIO 158
    • 13.13.3 RECENT DEVELOPMENT 158
  • 13.14 NATUS MEDICAL INCORPORATED 159
    • 13.14.1 COMPANY SNAPSHOT 159
    • 13.14.2 PRODUCT PORTFOLIO 159
    • 13.14.3 RECENT DEVELOPMENTS 160
  • 13.15 SOPHYSA 161
    • 13.15.1 COMPANY SNAPSHOT 161
    • 13.15.2 PRODUCT PORTFOLIO 161
    • 13.15.3 RECENT DEVELOPMENTS 162

14 QUESTIONNAIRE 163

15 RELATED REPORTS 166

LIST OF TABLES

  • TABLE 1 EUROPE HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 49
  • TABLE 2 EUROPE CONGENITAL HYDROCEPHALUS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 50
  • TABLE 3 EUROPE ACQUIRED HYDROCEPHALUS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 50
  • TABLE 4 EUROPE NORMAL-PRESSURE HYDROCEPHALUS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 51
  • TABLE 5 EUROPE EX-VACUO HYDROCEPHALUS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 51
  • TABLE 6 EUROPE HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 55
  • TABLE 7 EUROPE DIAGNOSTIC IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD MILLION) 56
  • TABLE 8 EUROPE DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 56
  • TABLE 9 EUROPE TREATMENT IN HYDROCEPHALUS MARKET, BY REGION, 2019-2028 (USD MILLION) 57
  • TABLE 10 EUROPE TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 57
  • TABLE 11 EUROPE SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 58
  • TABLE 12 EUROPE HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 58
  • TABLE 13 EUROPE SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 59
  • TABLE 14 EUROPE TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 60
  • TABLE 15 EUROPE HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 64
  • TABLE 16 EUROPE HOSPITALS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 65
  • TABLE 17 EUROPE CLINICS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 65
  • TABLE 18 EUROPE DIAGNOSTIC CENTERS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 66
  • TABLE 19 EUROPE ACADEMIC INSTITUTIONS AND RESEARCH ORGANIZATIONS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 66
  • TABLE 20 EUROPE SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 67
  • TABLE 21 EUROPE TREATMENT IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 67
  • TABLE 22 EUROPE HYDROCEPHALUS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 72
  • TABLE 23 EUROPE HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 73
  • TABLE 24 MEXICO HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 73
  • TABLE 25 EUROPE DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 73
  • TABLE 26 EUROPE TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 74
  • TABLE 27 EUROPE HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 74
  • TABLE 28 EUROPE HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 74
  • TABLE 29 EUROPE SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 75
  • TABLE 30 EUROPE TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 75
  • TABLE 31 EUROPE HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 75
  • TABLE 32 EUROPE SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 76
  • TABLE 33 EUROPE TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 76
  • TABLE 34 GERMANY HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 77
  • TABLE 35 GERMANY HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 77
  • TABLE 36 GERMANY DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 77
  • TABLE 37 GERMANY TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 78
  • TABLE 38 GERMANY HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 78
  • TABLE 39 GERMANY HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 78
  • TABLE 40 GERMANY SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 79
  • TABLE 41 GERMANY TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 79
  • TABLE 42 GERMANY HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 79
  • TABLE 43 GERMANY SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 80
  • TABLE 44 GERMANY TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 80
  • TABLE 45 FRANCE HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 81
  • TABLE 46 FRANCE HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 81
  • TABLE 47 FRANCE DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 81
  • TABLE 48 FRANCE TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 82
  • TABLE 49 FRANCE HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 82
  • TABLE 50 FRANCE HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 82
  • TABLE 51 FRANCE SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 83
  • TABLE 52 FRANCE TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 83
  • TABLE 53 FRANCE HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 83
  • TABLE 54 FRANCE SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 84
  • TABLE 55 FRANCE TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 84
  • TABLE 56 U.K. HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 85
  • TABLE 57 U.K. HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 85
  • TABLE 58 U.K. DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 85
  • TABLE 59 U.K. TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 86
  • TABLE 60 U.K. HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 86
  • TABLE 61 U.K. HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 86
  • TABLE 62 U.K. SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 87
  • TABLE 63 U.K. TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 87
  • TABLE 64 U.K. HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 87
  • TABLE 65 U.K. SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 88
  • TABLE 66 U.K. TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 88
  • TABLE 67 ITALY HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 89
  • TABLE 68 ITALY HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 89
  • TABLE 69 ITALY DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 89
  • TABLE 70 ITALY TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 90
  • TABLE 71 ITALY HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 90
  • TABLE 72 ITALY HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 90
  • TABLE 73 ITALY SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 91
  • TABLE 74 ITALY TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 91
  • TABLE 75 ITALY HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 91
  • TABLE 76 ITALY SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 92
  • TABLE 77 ITALY TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 92
  • TABLE 78 SPAIN HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 93
  • TABLE 79 SPAIN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 93
  • TABLE 80 SPAIN DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 93
  • TABLE 81 SPAIN TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 94
  • TABLE 82 SPAIN HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 94
  • TABLE 83 SPAIN HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 94
  • TABLE 84 SPAIN SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 95
  • TABLE 85 SPAIN TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 95
  • TABLE 86 SPAIN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 95
  • TABLE 87 SPAIN SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 96
  • TABLE 88 SPAIN TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 96
  • TABLE 89 RUSSIA HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 97
  • TABLE 90 RUSSIA HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 97
  • TABLE 91 RUSSIA DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 97
  • TABLE 92 RUSSIA TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 98
  • TABLE 93 RUSSIA HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 98
  • TABLE 94 RUSSIA HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 98
  • TABLE 95 RUSSIA SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 99
  • TABLE 96 RUSSIA TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 99
  • TABLE 97 RUSSIA HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 99
  • TABLE 98 RUSSIA SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 100
  • TABLE 99 RUSSIA TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 100
  • TABLE 100 TURKEY HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 101
  • TABLE 101 TURKEY HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 101
  • TABLE 102 TURKEY DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 101
  • TABLE 103 TURKEY TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 102
  • TABLE 104 TURKEY HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 102
  • TABLE 105 TURKEY HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 102
  • TABLE 106 TURKEY SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 103
  • TABLE 107 TURKEY TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 103
  • TABLE 108 TURKEY HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 103
  • TABLE 109 TURKEY SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 104
  • TABLE 110 TURKEY TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 104
  • TABLE 111 IRELAND HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 105
  • TABLE 112 IRELAND HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 105
  • TABLE 113 IRELAND DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 105
  • TABLE 114 IRELAND TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 106
  • TABLE 115 IRELAND HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 106
  • TABLE 116 IRELAND HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 106
  • TABLE 117 IRELAND SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 107
  • TABLE 118 IRELAND TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 107
  • TABLE 119 IRELAND HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 107
  • TABLE 120 IRELAND SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 108
  • TABLE 121 IRELAND TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 108
  • TABLE 122 BELGIUM HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 109
  • TABLE 123 MEXICO HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 109
  • TABLE 124 BELGIUM DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 109
  • TABLE 125 BELGIUM TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 110
  • TABLE 126 BELGIUM HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 110
  • TABLE 127 BELGIUM HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 110
  • TABLE 128 BELGIUM SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 111
  • TABLE 129 BELGIUM TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 111
  • TABLE 130 BELGIUM HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 111
  • TABLE 131 BELGIUM SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 112
  • TABLE 132 BELGIUM TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 112
  • TABLE 133 NETHERLANDS HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 113
  • TABLE 134 NETHERLANDS HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 113
  • TABLE 135 NETHERLANDS DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 113
  • TABLE 136 NETHERLANDS TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 114
  • TABLE 137 NETHERLANDS HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 114
  • TABLE 138 NETHERLANDS HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 114
  • TABLE 139 NETHERLANDS SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 115
  • TABLE 140 NETHERLANDS TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 115
  • TABLE 141 NETHERLANDS HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 115
  • TABLE 142 NETHERLANDS SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 116
  • TABLE 143 NETHERLANDS TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 116
  • TABLE 144 SWITZERLAND HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 117
  • TABLE 145 SWITZERLAND HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 117
  • TABLE 146 SWITZERLAND DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 117
  • TABLE 147 SWITZERLAND TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 118
  • TABLE 148 SWITZERLAND HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 118
  • TABLE 149 SWITZERLAND HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 118
  • TABLE 150 SWITZERLAND SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 119
  • TABLE 151 SWITZERLAND TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 119
  • TABLE 152 SWITZERLAND HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 119
  • TABLE 153 SWITZERLAND SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 120
  • TABLE 154 SWITZERLAND TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 120
  • TABLE 155 REST OF EUROPE HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 121

LIST OF FIGURES

  • FIGURE 1 EUROPE HYDROCEPHALUS MARKET: SEGMENTATION 22
  • FIGURE 2 EUROPE HYDROCEPHALUS MARKET: DATA TRIANGULATION 25
  • FIGURE 3 EUROPE HYDROCEPHALUS MARKET: DROC ANALYSIS 26
  • FIGURE 4 EUROPE HYDROCEPHALUS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS 27
  • FIGURE 5 EUROPE HYDROCEPHALUS MARKET: COMPANY RESEARCH ANALYSIS 27
  • FIGURE 6 EUROPE HYDROCEPHALUS MARKET: INTERVIEW DEMOGRAPHICS 29
  • FIGURE 7 EUROPE HYDROCEPHALUS MARKET: DBMR MARKET POSITION GRID 30
  • FIGURE 8 EUROPE HYDROCEPHALUS MARKET: VENDOR SHARE ANALYSIS 31
  • FIGURE 9 EUROPE HYDROCEPHALUS MARKET: SEGMENTATION 34
  • FIGURE 10 INCREASING INCIDENCE OF NEUROLOGICAL CONDITIONS IS EXPECTED TO DRIVE THE EUROPE HYDROCEPHALUS MARKET IN THE FORECAST PERIOD OF 2024 TO 2031 35
  • FIGURE 11 CONGENITAL HYDROCEPHALUS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE HYDROCEPHALUS MARKET IN 2024 & 2031 35
  • FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE HYDROCEPHALUS MARKET 39
  • FIGURE 13 EUROPE HYDROCEPHALUS MARKET: BY TYPE, 2023 47
  • FIGURE 14 EUROPE HYDROCEPHALUS MARKET: BY TYPE, 2024-2031 (USD THOUSAND) 48
  • FIGURE 15 EUROPE HYDROCEPHALUS MARKET: BY TYPE, CAGR (2024-2031) 48
  • FIGURE 16 EUROPE HYDROCEPHALUS MARKET: BY TYPE, LIFELINE CURVE 49
  • FIGURE 17 EUROPE HYDROCEPHALUS MARKET: BY DIAGNOSTICS & TREATMENT, 2023 53
  • FIGURE 18 EUROPE HYDROCEPHALUS MARKET: BY DIAGNOSTICS & TREATMENT, 2024-2031 (USD THOUSAND) 54
  • FIGURE 19 EUROPE HYDROCEPHALUS MARKET: BY DIAGNOSTICS & TREATMENT, CAGR (2024-2031) 54
  • FIGURE 20 EUROPE HYDROCEPHALUS MARKET: BY DIAGNOSTICS & TREATMENT, LIFELINE CURVE 55
  • FIGURE 21 EUROPE HYDROCEPHALUS MARKET: BY END USERS, 2023 62
  • FIGURE 22 EUROPE HYDROCEPHALUS MARKET: BY END USERS, 2024-2031 (USD THOUSAND) 63
  • FIGURE 23 EUROPE HYDROCEPHALUS MARKET: BY END USERS, CAGR (2024-2031) 63
  • FIGURE 24 EUROPE HYDROCEPHALUS MARKET: BY END USERS, LIFELINE CURVE 64
  • FIGURE 25 EUROPE HYDROCEPHALUS MARKET: SNAPSHOT (2023) 71
  • FIGURE 26 EUROPE HYDROCEPHALUS MARKET: COMPANY SHARE 2023 (%) 122
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!